Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication related to notice of loss of equity share certificate.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the stock exchanges about a newspaper advertisement published in Business Standard on 2nd July 2025 regarding the loss/misplacement of an equity share certificate. The shareholder, Subhashchandra Wamanrao Korpe, holding 600 equity shares (Folio No. 0085780, Certificate No. 13868, Distinctive Nos. 59197122-59197721), has applied for a duplicate share certificate. The public has been warned against purchasing or dealing with these shares, and any claims must be submitted to the company's Registrar and Transfer Agent (MUFG Intime India Private Limited) within 15 days from the date of publication.
This is a routine procedural filing with no material impact on the company's operations, financials, or stock price. It is a standard regulatory disclosure required when a shareholder reports a lost share certificate and seeks a duplicate.